DESITIN - SUCCESS IN CNS

Market share by territories

Due to its complete range in antiepileptics Desitin has been able to achieve high ranks  in markets where  it is present with own sales forces as depicted in the table below.

 

 

N3A (Epilepsy) Market (in Packs)

 

No. 1           Estonia, Norway

No. 2-5       Germany, Czech Republic, Denmark, Slovakia, Switzerland  

 

 

VPA (Sodium Valproate) Market (in Packs)

 

No. 1            Germany, Czech Republic, Estonia, Norway  

No. 2-5        Denmark, Romania, Slovakia, Sweden, Switzerland